Valproic Acid Regulates α-Synuclein Expression through JNK Pathway in Rat Primary Astrocytes |
Kim, Jung Nam
(Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University)
Kim, Min Kyeong (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Cho, Kyu Suk (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Choi, Chang Soon (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Park, Seung Hwa (Department of Anatomy, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Yang, Sung-Il (Department of Pharmacology, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Joo, So Hyun (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Park, Jin Hee (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Bahn, Geonho (Department of Psychiatry, College of Medicine, Kyung Hee University) Shin, Chan Young (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Lee, He-Jin (Department of Anatomy, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Han, Seol-Heui (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) Kwon, Kyoung Ja (Department of Neuroscience, SMART Institute Advanced Biomedical Sciences, School of Medicine, Konkuk University) |
1 | Karpinar, D. P., Balija, M. B., Kügler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., Kim, H. Y., Taschenberger, G., Falkenburger, B. H., Heise, H., Kumar, A., Riedel, D., Fichtner, L., Voigt, A., Braus, G. H., Giller, K., Becker, S., Herzig, A., Baldus, M., Jackle, H., Eimer, S., Schulz, J. B., Griesinger, C. and Zweckstetter, M. (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J. 28, 3256-3268. DOI ScienceOn |
2 | Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A. and Yao, T. P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727-738. DOI ScienceOn |
3 | Kim, S. H., Kang, H. J., Na, H. and Lee, M. O. (2010) Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. Breast Cancer Res. 12, R22. DOI ScienceOn |
4 | Kruger. R., Kuhn. W., Muller. T., Woitalla. D., Graeber. M., Kosel. S., Przuntek. H., Epplen. J. T., Schols, L. and Riess, O. (1998) Ala-30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108. DOI ScienceOn |
5 | Alves Da Costa, C., Paitel, E., Vincent, B. and Checler, F. (2002) Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J. Biol. Chem. 277, 50980-50984. DOI ScienceOn |
6 | Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N. and Mouradian, M. M. (1999) Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274, 33855-33858. DOI |
7 | Bjorkblom, B., Padzik, A., Mohammad, H., Westerlund, N., Komulainen, E., Hollos, P., Parviainen, L., Papageorgiou, A. C., Iljin, K., Kallioniemi, O., Kallajoki, M., Courtney, M. J., Mågård, M., James, P. and Coffey, E.T. (2012) c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells. Mol. Cell. Biol. 32, 3513-3526. DOI |
8 | Cao, C., Lu, S., Kivlin, R., Wallin, B., Card, E., Bagdasarian, A., Tamakloe, T., Wang, W. J., Song, X., Chu, W. M., Kouttab, N., Xu, A. and Wan, Y. (2009) SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J. Cell. Mol. Med. 13, 3632-3643. DOI |
9 | Catalano, M. G., Poli, R., Pugliese, M., Fortunati, N. and Boccuzzi, G. (2007) Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Endocr. Relat. Cancer 14, 839-845. DOI ScienceOn |
10 | Shin, C. Y., Choi, J. W., Jang, E. S., Ryu, J. H., Kim, W. K., Kim, H. C. and Ko, K. H. (2001) Glucocorticoids exacerbate peroxynitrite mediated potentiation of glucose deprivation-induced death of rat primary astrocytes. Brain Res. 923, 163-171. DOI ScienceOn |
11 | Sidhu, A., Wersinger, C. and Vernier, P. (2004) Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J. 18, 637-647. DOI ScienceOn |
12 | Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C. and Jiang, S. W. (2010) Nonhistone protein acetylation as cancer therapy targets. Expert Rev. Anticancer Ther. 10, 935-954. DOI ScienceOn |
13 | Sofroniew, M. and Vinters, H. B. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35. DOI ScienceOn |
14 | Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. and Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840. DOI ScienceOn |
15 | Su, M., Shi, J. J., Yang, Y. P., Li, J., Zhang, Y. L., Chen, J., Hu, L. F. and Liu, C. F. (2011) HDAC6 regulates aggresome-autophagy degradation pathway of alpha-synuclein in response to MPP+-induced stress. J. Neurochem. 117, 112-120. DOI ScienceOn |
16 | Tonges, L., Planchamp, V., Koch, J.C., Herdegen, T., Bahr, M. and Lingor, P. (2011) JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro. J. Mol. Neurosci. 45, 284-293. DOI ScienceOn |
17 | Ushijima, H. and Maeda, M. (2012) cAMP-dependent proteolysis of GATA-6 is linked to JNK-signaling pathway. Biochem. Biophys. Res. Commun. 423, 679-683. DOI ScienceOn |
18 | Weidenfeld-Baranboim, K., Koren, L. and Aronheim, A. (2011) Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation. Biochem. J. 436, 661-669. DOI ScienceOn |
19 | Vekrellis, K. and Stefanis, L. (2012) Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies. Expert Opin. Ther. Targets 16, 421-432. DOI ScienceOn |
20 | Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. and Rubinsztein, D. C. (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009-25013. DOI ScienceOn |
21 | Yamauchi, J., Torii, T., Kusakawa, S., Sanbe, A., Nakamura, K., Takashima, S., Hamasaki, H., Kawaguchi, S., Miyamoto, Y. and Tanoue, A. (2010) The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth diseaseassociated mutant Rab7 through the JNK signaling pathway. J. Neurosci. Res. 88, 3189-3197. DOI ScienceOn |
22 | Lee, H. J., Patel, S. and Lee, S. J. (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 6016-6024. DOI ScienceOn |
23 | Lee, H. J., Shin, S. Y., Choi, C., Lee, Y. H. and Lee, S. J. (2002) Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem. 277, 5411-5417. DOI ScienceOn |
24 | Leng, Y. and Chuang, D. M. (2006) Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J. Neurosci. 26, 7502-7512. DOI ScienceOn |
25 | L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C. and Marchetti, B. (2010) Glia as a turning point in the therapeutic strategy of Parkinson's disease. CNS Neurol. Disord. Drug Targets 9, 349-372. DOI |
26 | Monti, B., Polazzi, E. and Contestabile, A. (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr. Mol. Pharmacol. 2, 95-109. DOI |
27 | Li, K., Wang, R., Lozada, E., Fan, W., Orren, D. K. and Luo, J. (2010) Acetylation of WRN protein regulates its stability by inhibiting ubiquitination. PloS One 5, e10341. DOI ScienceOn |
28 | Marchetti, B. (1997) Cross-talk signals in the CNS: Role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH) neuron-astroglia interactive network. Front. Biosci. 2, d88-125. |
29 | Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M. and Contestabile, A. (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox. Res. 17, 130-141. DOI |
30 | Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A. and Edwards, R. H. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79. DOI ScienceOn |
31 | Park, J. Y., Paik, S. R., Jou, I. and Park, S. M. (2008) Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease. Glia 56, 1215-1223. DOI ScienceOn |
32 | Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di, I. G., Golbe, L. I. and Nussbaum, R. L. (1997) Mutation in the alphasynuclein gene identifi ed in families with Parkinson's disease. Science 276, 2045-2047. DOI ScienceOn |
33 | Seo, J. H., Rah, J. C., Choi, S. H., Shin, J. K., Min, K., Kim, H. S., Park, C. H., Kim, S., Kim, E. M., Lee, S. H., Lee, S., Suh, S. W. and Suh, Y. H. (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J. 16, 1826-1828. |
34 | Glozak, M. A., Sengupta, N., Zhang, X. and Seto, E. (2005) Acetylation and deacetylation of non-histone proteins. Gene 363, 15-23. DOI ScienceOn |
35 | Colombo, R., Caldarelli, M., Mennecozzi, M., Giorgini, M. L., Sola, F., Cappella, P., Perrera, C., Depaolini, S. R., Rusconi, L., Cucchi, U., Avanzi, N., Bertrand, J. A., Bossi, R. T., Pesenti, E., Galvani, A., Isacchi, A., Colotta, F., Donati, D. and Moll, J. (2010) Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. Cancer Res. 70, 10255-10264. DOI ScienceOn |
36 | Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K. and Chen, G. (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23, 7311-7316. |
37 | Geng, H., Liu, Q., Xue, C., David, L., Beer, T. M., Thomas, G. V., Dai, M. S. and Qian, D. Z. (2012) protein stability is increased by acetylation at lysine-K709. J. Biol. Chem. 287, 35496-35505. DOI |
38 | Jensen, P. J., Alter, B. J. and O'Malley, K. L. (2003) Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J. Neurochem. 86, 196-209. |
39 | Joo, S. H., Kwon, K. J., Kim, J. W., Hasan, M. R., Lee, H. J., Han, S. H. and Shin, C. Y. (2010) Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells. Neurosci. Lett. 469, 352-356. DOI ScienceOn |
40 | Kanai, H., Sawa, A., Chen, R. W., Leeds, P. and Chuang, D. M. (2004) Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J. 4, 336-344. DOI ScienceOn |
41 | Kang, S. A., Na, H., Kang, H. J., Kim, S. H., Lee, M. H. and Lee, M. O. (2010) Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1. Biochem. Pharmacol. 80, 867-873. DOI ScienceOn |